Featured Articles

Stay up to date on IPM’s work and latest trends in the field.

January 24, 2012

Reflections for 2012: A Message from IPM CEO Dr. Zeda Rosenberg

by Dr. Zeda Rosenberg, chief executive officer, International Partnership for MicrobicidesAs 2012 begins, I would like to reflect on what 2011 meant for IPM, HIV prevention and women’s health — and... More »

December 22, 2011

Science Names HIV "Treatment as Prevention" Trial Top 2011 Breakthrough

Science has named as its breakthrough of the year a clinical trial, HPTN 052, which found that people infected with HIV who initiate antiretroviral therapy immediately reduce the risk of heterosexual... More »

November 25, 2011

VOICE Study Discontinues Tenofovir Gel Arm

November 25, 2011 —Today, the Microbicide Trials Network (MTN) announced a change to its VOICE study, a clinical trial evaluating the safety and effectiveness of two different antiretroviral (ARV)-... More »

October 03, 2011

Webcast: Global Health Leaders Discuss Strategies for Maternal and Child Health Beyond 2015

IPM CEO Dr. Zeda Rosenberg discusses how gender equality and HIV prevention technologies can lead to long-term maternal health Dr. Zeda Rosenberg, CEO of the International Partnership for... More »

September 28, 2011

New Development in VOICE Study: oral tenofovir arm discontinued

September 28, 2011 —Today the Microbicide Trials Network (MTN) announced a change to its VOICE study, a clinical trial designed to evaluate the safety and effectiveness of two different... More »

Pages